Dr. Sayed M. Yossef, MD

Dr. Yossef practices at The Surgical Hospital at Southwoods in Youngstown, Ohio, part of The Surgical Hospital at Southwoods.

Dr. Yossef's NPI, 1487657219, was assigned on May 24, 2005. Dr. Yossef graduated from University of Pittsburgh School of Medicine in 1990. Dr. Yossef holds Ohio license 35056182Y.

Dr. Yossef's primary practice is The Surgical Hospital at Southwoods, at 7630 Southern Blvd, Youngstown, OH 44512 in Mahoning County. The practice phone is (330) 729-8000.

Dr. Yossef's primary practice is The Surgical Hospital at Southwoods in Youngstown, Ohio, part of The Surgical Hospital at Southwoods. Dr. Yossef is also affiliated with Mercy Health - St. Elizabeth Youngstown Hospital. The medical group on file is Southwoods Physician Services. Dmand AI also links Dr. Yossef to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yossef practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Yossef's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Yossef is licensed in Ohio.

CMS data shows 673 Medicare services from Dr. Yossef across 10 procedure codes in 2024, for 349 Medicare patients. Medicare paid $59,830 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 349 Medicare patients who saw Dr. Yossef in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yossef's median patient age at 65, with 60% women.

In 2024, Dr. Yossef wrote 3,703 Medicare Part D claims for 776 patients. 84% of them were for generic drugs. CMS names the drug for 3,564 of them, across 47 drugs with 11 or more claims each, at $1,425,118 in total drug cost. In 2023, CMS named 4,174 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Yossef for performance year 2024, reported as part of a group. Dr. Yossef accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 164 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Yossef, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Yossef in 2020. Dr. Yossef's most frequent co-author is John H. Abernethy, MD.

Dmand AI links Dr. Yossef to 7 clinical trials. 3 are still active or recruiting. Conditions studied include Colitis, Ulcerative, Colitis and Alzheimer Disease. Eli Lilly and Company sponsors the most, 7. Open Payments lists research payments to Dr. Yossef that name 5 trials.

CMS Open Payments shows 939 general payments to Dr. Yossef from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Allergan Inc. paid the most, $35,793. It also lists 10 research payments totaling $25,825 from 2018 to 2023, naming 5 clinical trials.

Dr. Yossef graduated from University of Pittsburgh School of Medicine in 1990.